Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls
Annelies H. Boekhout, Anne Rogiers, Katarzyna Jóźwiak, et al.
Acta Oncologica (2020) Vol. 60, Iss. 1, pp. 69-77
Open Access | Times Cited: 23

Showing 23 citing articles:

Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life
Thomas U. Schulz, Sarah Zierold, Michael Max Sachse, et al.
European Journal of Cancer (2022) Vol. 176, pp. 88-99
Closed Access | Times Cited: 41
Prevalence & Odds of Anxiety & Depression in Cutaneous Malignant Melanoma: A Proportional Meta-analysis & Regression
Garikai Kungwengwe, Chloe Gowthorpe, Stephen R. Ali, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 1, pp. 24-35
Closed Access | Times Cited: 6
Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy
Sidsel Pedersen, Rikke Boedker Holmstroem, Annika von Heymann, et al.
Acta Oncologica (2023) Vol. 62, Iss. 1, pp. 62-69
Open Access | Times Cited: 13
Psychological and behavioral symptoms in patients with melanoma: A systematic review and meta‐analysis
Josefine T. Danielsen, Louise Strøm, Sofie Møgelberg Knutzen, et al.
Psycho-Oncology (2023) Vol. 32, Iss. 8, pp. 1208-1222
Open Access | Times Cited: 13
Quality of life, neurocognitive functioning, psychological issues, sexuality and comorbidity more than 2 years after commencing immune checkpoint inhibitor treatment
Wellington Candido, Annemarie C. Eggen, Mathilde Jalving, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e011168-e011168
Open Access
Immune Checkpoint Inhibitors and Cognition in Adults with Cancer: A Scoping Review
Síofra Hearne, Michelle N. McDonnell, Amanda Lavan, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 928-928
Open Access
Health‐related quality of life in survivors of advanced melanoma treated with anti‐PD1‐based immune checkpoint inhibitors
Esmée Lauren Looman, Phil F. Cheng, Julia Lai‐Kwon, et al.
Cancer Medicine (2023) Vol. 12, Iss. 11, pp. 12861-12873
Open Access | Times Cited: 7
An eHealth App (CAPABLE) Providing Symptom Monitoring, Well-Being Interventions, and Educational Material for Patients With Melanoma Treated With Immune Checkpoint Inhibitors: Protocol for an Exploratory Intervention Trial
Itske Fraterman, Barbara M. Wollersheim, Valentina Tibollo, et al.
JMIR Research Protocols (2023) Vol. 12, pp. e49252-e49252
Open Access | Times Cited: 7
Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment
Elin Aamdal, Eva Skovlund, Kari Dolven Jacobsen, et al.
ESMO Open (2022) Vol. 7, Iss. 5, pp. 100588-100588
Open Access | Times Cited: 9
Real-World Effectiveness, Safety, and Health-Related Quality of Life in Patients Receiving Adjuvant Nivolumab for Melanoma in Belgium and Luxembourg: Results of PRESERV MEL
Anne Rogiers, L. Willemot, Laura McDonald, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4823-4823
Open Access | Times Cited: 5
The Symptom Experience of Patients with Advanced Melanoma Undergoing Immune Checkpoint Inhibitor (ICI) Therapy
Natalie Jackson-Carroll, Constance Johnson, Hussein A. Tawbi, et al.
Seminars in Oncology Nursing (2024) Vol. 40, Iss. 1, pp. 151574-151574
Closed Access | Times Cited: 1
Survival is not enough: understanding the mental burden of cutaneous melanoma
Mees Egeler, Bettina Ryll
British Journal of Dermatology (2024) Vol. 191, Iss. 1, pp. 4-5
Closed Access | Times Cited: 1
“Skin rashes” and immunotherapy in melanoma: distinct dermatologic adverse events and implications for therapeutic management
Pietro Sollena, Simone Cappilli, Francesco Federico, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 18, Iss. 3
Open Access | Times Cited: 10
Systemic therapy timing and use in patients with advanced melanoma at the end of life: A retrospective cohort study
P. E. A. van Lith, K. Schreuder, Mathilde Jalving, et al.
The Journal of Dermatology (2023) Vol. 51, Iss. 4, pp. 584-591
Open Access | Times Cited: 3
A systematic review of patient-reported outcome measures for advanced skin cancer patients
Myrna Eliann Reinhardt, Tiffany Sun, C. Pan, et al.
Archives of Dermatological Research (2022) Vol. 315, Iss. 6, pp. 1473-1480
Closed Access | Times Cited: 5
Soziale Teilhabe und Hautkrebs während der COVID-19-Pandemie
Jacqueline Niewolik, Marie Mikuteit, Dominik Schröder, et al.
Deleted Journal (2023) Vol. 74, Iss. 2, pp. 108-113
Open Access | Times Cited: 2
Health-state utilities in long-term advanced melanoma survivors comparable with the general population
Mees Egeler, Lonneke V. van de Poll‐Franse, Renaud Tissier, et al.
Quality of Life Research (2023) Vol. 32, Iss. 9, pp. 2517-2525
Closed Access | Times Cited: 2
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st–3rd, 2022—Naples, Italy)
Paolo A. Ascierto, Sanjiv S. Agarwala, Allison Betof Warner, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Melanoma and Quality of Life
Robyn P.M. Saw, Iris Bartula, Julie Winstanley, et al.
Springer eBooks (2022), pp. 439-466
Closed Access | Times Cited: 4
Muscle atrophy and organ enlargement associated with quality of life during systemic therapy for melanoma: findings from an AI-based body composition analysis
Itske Fraterman, Laura Estacio Cerquin, Kelly M. de Ligt, et al.
European Radiology (2024)
Closed Access
Impact of Immune Checkpoint Inhibitor Therapy on Quality of Life in Patients With Advanced Melanoma
Natalie Jackson-Carroll, Meagan Whisenant, Stacey Crane, et al.
Cancer Nursing (2023)
Closed Access | Times Cited: 1
An eHealth App (CAPABLE) Providing Symptom Monitoring, Well-Being Interventions, and Educational Material for Patients With Melanoma Treated With Immune Checkpoint Inhibitors: Protocol for an Exploratory Intervention Trial (Preprint)
Itske Fraterman, Barbara M. Wollersheim, Valentina Tibollo, et al.
(2023)
Open Access
Longitudinal evaluation of health-related quality of life after removal of high-risk melanoma in a setting where adjuvant therapy is not available
Jovana Sladojevic, Jelena Dotlić, Tatjana Gazibara, et al.
Archives of Dermatological Research (2023) Vol. 316, Iss. 1
Closed Access
Page 1

Scroll to top